Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Immunicum AB (publ) (ST: IMMU)

 
IMMU Technical Analysis
4
As on 9th May 2025 IMMU STOCK Price closed @ 5.78 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3.92 & Strong Buy for SHORT-TERM with Stoploss of 0.54 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IMMUSTOCK Price

Open 6.12 Change Price %
High 6.12 1 Day -0.21 -3.51
Low 5.57 1 Week 0.54 10.31
Close 5.78 1 Month -0.92 -13.73
Volume 15929 1 Year 5.30 1104.17
52 Week High 10.55 | 52 Week Low 0.42
 
ST Sweden Most Active Stocks
FING-B 0.02 0.00%
HDW-B 0.00 %
ENERS 0.00 %
WYLD 0.04 0.00%
S2M 0.01 0.00%
QUIA 0.01 0.00%
SBB-B 3.85 -3.99%
IMMNOV 0.40 17.65%
LUNE 21.97 6.65%
QLINEA 0.04 0.00%
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
SPIFF 0.04 33.33%
RAY-B 314.50 30.77%
RAY-B 314.50 30.77%
LIDDS 0.05 25.00%
SCOUT 0.22 22.22%
IMMNOV 0.40 17.65%
CHECK 9.40 17.50%
COINETHE 177.19 16.67%
ELIC 5.12 16.36%
 
ST Sweden Top Losers Stocks
BUFAB 81.74 -79.96%
SECI 0.01 -50.00%
SECI 0.01 -50.00%
ZICC 0.25 -34.21%
AUR 0.82 -31.67%
AUR 0.82 -31.67%
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
 
 
IMMU
Daily Charts		 IMMU
Intraday Charts		 Whats New @
Bazaartrend		 IMMU
Free Analysis
 
IMMU Important Levels Intraday
RESISTANCE6.84
RESISTANCE6.50
RESISTANCE6.29
RESISTANCE6.08
SUPPORT5.48
SUPPORT5.27
SUPPORT5.06
SUPPORT4.72
 
IMMU Forecast May 2025
Share
4th UP Forecast6.49
3rd UP Forecast6.26
2nd UP Forecast6.12
1st UP Forecast5.98
1st DOWN Forecast5.58
2nd DOWN Forecast5.44
3rd DOWN Forecast5.3
4th DOWN Forecast5.07
 
IMMU Weekly Forecast
4th UP Forecast6.30
3rd UP Forecast6.13
2nd UP Forecast6.03
1st UP Forecast5.93
1st DOWN Forecast5.63
2nd DOWN Forecast5.53
3rd DOWN Forecast5.43
4th DOWN Forecast5.26
 
IMMU Forecast2025
4th UP Forecast26.61
3rd UP Forecast19.93
2nd UP Forecast15.8
1st UP Forecast11.67
1st DOWN Forecast-0.11
2nd DOWN Forecast-4.24
3rd DOWN Forecast-8.37
4th DOWN Forecast-15.05
 
 
IMMU Other Details
Segment EQ
Market Capital 696906432.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IMMU Address
IMMU
 
IMMU Latest News
 
Your Comments and Response on Immunicum AB (publ)
 
IMMU Business Profile
Immunicum AB (publ), a biopharmaceutical company, develops immunotherapies and relapse vaccines for the treatment of cancer. Its lead product is ilixadencel, which is in Phase II clinical trial for the treatment of kidney cancer; and Phase Ib/II clinical trial for the treatment of head and neck cancer, non-small cell lung cancer, and gastric cancer, as well as has completed Phase I/II clinical trial to treat liver cancer and gastrointestinal stromal tumors. The company's products also comprise DCP-001, which is in Phase II ADVANCE-II clinical trial for the treatment of acute myeloid leukemia; and Phase I ALISON clinical trial for the treatment of ovarian cancers. It has a collaboration agreement with Merck KGaA and Pfizer Inc. to evaluate ilixadencel in combination with avelumab in multi-indication Phase Ib/II study; and research collaboration with Icahn School of Medicine At Mount Sinai. The company is headquartered in Stockholm, Sweden. Address: Oestermalmstorg 5, Stockholm, Sweden, 114 42
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service